Company: 

Assign DMB

Assign DMB

Services Niche provided to Assign DMB included:

  • General editorial and medical writing support
  • Writing of clinical protocols
  • Writing of the clinical study reports
What our client said

"Over the time that we have worked with the Niche team we have found all their representatives to be dedicated, knowledgeable and professional in their approach; executing their responsibilities in a skilled manner both on time and on budget."

photophotophotophotophoto

Julian Larcher-Senn

Assign DMB




Request copy of the testimonial
Project background
Assign DMB is a clinical research organisation (CRO) based in Innsbruck, Austria, specialising in providing comprehensive services for clinical trials. Founded in 2005 by Dr. Anton Klingler, the company initially focused on clinical data management and biostatistics. Over two decades, Assign DMB expanded its offerings to include safety management, project management and medical writing, serving sponsors involved in drug, vaccine and medical device studies across all clinical phases. In 2024, Assign DMB was acquired by P95, a global CRO headquartered in Belgium with a strong focus on vaccines and infectious diseases. This acquisition has integrated Assign DMB’s expertise with P95’s global capabilities, allowing for an expanded reach in delivering epidemiology and clinical solutions worldwide. Assign DMB has supported studies in over 40 countries, emphasizing data quality and regulatory compliance to optimize study outcomes.
Delivery

As a small company, Assign’s business model relied on bespoke service providers like Niche to deliver essential aspects of their business delivery model. Niche partnered with Assign, providing regulatory writing and editorial services across a broad portfolio of research projects including those in oncology, asthma and gastroenterological therapy areas. Over a 10-year period, Niche played a pivotal role in converting Assign's statistical outputs into clinical study reports for their Sponsor clients. Niche was instrumental in delivering a high-quality service built on a strong working relationship. The Niche medical writing team was dedicated to providing a premium service through the application of their experience through a professional approach, executing their responsibilities on time and on budget, with clear and efficient communication. The end result was an agile, seamless integration between Niche and Assign teams for generation of critical deliverables and actualisation of project goals, according to client needs.

 

Related Case studies

Astex Pharmaceuticals

Medical writing

Specialising in the discovery and development of small-molecule drugs for oncology and central nervous system disorders.

Niche provided Astex with expert regulatory writing across their oncology pipeline, delivering clinical protocols, study.

read more

Nabriva Therapeutics

Medical writing

Nabriva Therapeutics is committed to developing new antibiotics to treat infectious diseases.

Niche supported Nabriva's antibiotic lefamulin from early clinical protocols all the way to FDA, EMA and Health Canada.

read more

Adaptimmune

Medical writing

QC review of an IB update for uzatresgene autoleucel, one of Adaptimmune’s TCR-based therapies.

Niche delivered rigorous QC and medical writing support across Adaptimmune's full suite of regulatory documents, keeping.

read more

Synairgen plc

Medical writing

A specialist respiratory biotech company whose primary focus is developing our investigative inhaled IFN-β for the treatment of severe viral lung infections.

At the height of the pandemic, Niche's rapid manuscript writing helped Synairgen publish their landmark interferon beta.

read more

Recardio Inc

Medical writing

Recardio Inc is a life science company that focuses on drug-based regenerative therapeutic modalities for treatments of cardiovascular diseases.

From Phase 2 through to the global Phase 3 HEAL-MI trial, Niche has been Recardio's trusted writing and regulatory.

read more

ViiV Healthcare

Medical writing

A specialist pharmaceutical company dedicated to HIV medicines and research with an extensive portfolio of prescription medicines.

Putting patients first, Niche supported ViiV Healthcare's global HIV outreach programmes with medical writing,.

read more

British Society for Haematology

Medical writing

BSH is the UK’s largest haematology organisation, promoting excellence within the field and supporting professional development.

Over a decade and 20+ guidelines later, Niche remains the BSH's trusted partner for raising haematology care standards.

read more

FRAILomic

Medical writing

The FRAILOMIC initiative was an international research project

Niche built and coordinated the full communications strategy for this 20-institution European initiative, turning.

read more

Cleothena Enterprises Pty Ltd

Medical writing

Cleothena Enterprises Pty Ltd. is a forward-thinking biotechnology company focused on advancing innovative therapeutic solutions.

When stalled regulatory documentation threatened to derail their neurological programme, Cleothena turned to Niche —.

read more

BioKinetic Europe

Medical writing

A clinical research organisation specialising in early-phase clinical trials focusing on pharmacokinetic, pharmacodynamic and first-in-human studies.

A trusted writing partner to this Belfast-based early-phase CRO for over a decade, Niche turned BioKinetic Europe's.

read more

Scandinavian Development Services

Medical writing

Providing regulatory and medical writing support to meet client needs

Niche served as the English-language regulatory writing backbone for this Nordic consultancy, producing IBs, IMPDs and.

read more

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility